A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/30 (2006.01)
Patent
CA 2582552
The invention provides an insulin-like growth factor-1 (IGF-1) receptor ligand carrying a therapeutic radionuclide for treatment of cancer is provided. A method of treating cancer using the IGF-1 receptor ligand carrying a therapeutic radionuclide is also provided. An anti-cancer therapeutic agent containing an IGF-1 receptor ligand linked to a toxin is also provided, as are methods of using the toxin conjugates for treatment of cancer.
La présente invention concerne un ligand du récepteur du facteur de croissance insulinomimétique de type 1 (IGF-1) transportant un radionucléide thérapeutique pour traiter un cancer. La présente invention concerne une méthode permettant de traiter un cancer au moyen du ligand du récepteur IGF-1 transportant un radionucléide thérapeutique. L'invention concerne également un agent thérapeutique antinéoplasique contenant un ligand du récepteur IGF-1 lié à une toxine, ainsi que des méthodes qui consistent à utiliser les conjugués de toxines pour traiter un cancer.
Gowling Lafleur Henderson Llp
Igf Oncology Llc
LandOfFree
Toxins and radionuclides coupled to igf-1 receptor ligands... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Toxins and radionuclides coupled to igf-1 receptor ligands..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Toxins and radionuclides coupled to igf-1 receptor ligands... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1946066